Penetration of cefotaxime and desacetylcefotaxime into skin blister fluid

1982 ◽  
Vol 10 (3) ◽  
pp. 193-196 ◽  
Author(s):  
Tom Bergan ◽  
Tore Kalager ◽  
Kjell Block Hellum ◽  
Claus Ola Solberg
Keyword(s):  
2003 ◽  
Vol 47 (5) ◽  
pp. 1771-1773 ◽  
Author(s):  
Dana Maglio ◽  
Renli Teng ◽  
Per T. Thyrum ◽  
Charles H. Nightingale ◽  
David P. Nicolau

ABSTRACT The pharmacokinetic disposition of meropenem, administered at 500 mg every 8 h, in plasma and cantharidin-induced blister fluid is described. Peak meropenem concentrations in blister fluid lagged behind peak meropenem concentrations in plasma, while a lower elimination rate from blister fluid was also noted. The mean penetration of meropenem into blister fluid was 67%. The pharmacokinetic profile of meropenem in blister fluid supports the utility of this dose in the management of skin and soft tissue infections.


2000 ◽  
Vol 44 (5) ◽  
pp. 1352-1355 ◽  
Author(s):  
Andrej Trampuz ◽  
Markus Wenk ◽  
Zarko Rajacic ◽  
Werner Zimmerli

ABSTRACT The pharmacokinetics of levofloxacin in serum and in skin blister fluid (SBF) was determined for 20 volunteers after a single 500-mg oral dose of levofloxacin. In addition, ex vivo bactericidal activity of SBF against Streptococcus pneumoniae and Staphylococcus aureus was studied. SBF containing levofloxacin and granulocytes killed 5.2 log of Streptococcus pneumoniae bacteria and 2.0 log of Staphylococcus aureus bacteria during a 6-h incubation.


1986 ◽  
Vol 17 (6) ◽  
pp. 795-800 ◽  
Author(s):  
T. Kalager ◽  
A. Digranes ◽  
T. Bergan ◽  
T. Rolstad

1990 ◽  
Vol 22 (2) ◽  
pp. 211-215 ◽  
Author(s):  
Monika Schäfer-Korting ◽  
Hans Christian Korting ◽  
Andreas Lukacs ◽  
Jos Heykants ◽  
Hans Behrendt

1996 ◽  
Vol 288 (12) ◽  
pp. 771-773 ◽  
Author(s):  
Knut Brockow ◽  
Dietrich Abeck ◽  
Klaus Hermann ◽  
Jahannes Ring

1983 ◽  
Vol 25 (6) ◽  
pp. 825-827 ◽  
Author(s):  
A. Nowak ◽  
M. Kadyk�w ◽  
A. Klimowicz
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document